...
首页> 外文期刊>Brain research >Cortical spreading depression (CSD)-induced tolerance to transient focal cerebral ischemia in halothane anesthetized rats is affected by anesthetic level but not ATP-sensitive potassium channels.
【24h】

Cortical spreading depression (CSD)-induced tolerance to transient focal cerebral ischemia in halothane anesthetized rats is affected by anesthetic level but not ATP-sensitive potassium channels.

机译:皮质扩散抑制(CSD)对氟烷麻醉大鼠的瞬时局灶性脑缺血的耐受性受到麻醉水平但不是ATP敏感钾通道的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We investigated the participation of ATP-sensitive potassium (K(ATP)) channels, adenosine A1 receptors, and the effects of different levels of halothane anesthesia in the development of CSD-induced ischemic tolerance. To elicit CSD, 0.5 M KCl was applied for 2 h to the right hemisphere of halothane anesthetized male Wistar rats. The inhalation concentration of halothane during CSD was maintained at 0.5% (n = 8), 1.0% (n = 8), or 2.0% (n = 8). For control animals, saline was applied instead of KCl (n = 8). To inhibit K(ATP) channels or adenosine A1 receptors, glibenclamide (0.1 mg/kg icv; n = 8), 5-hydroxydeconaoate (5-HD; 100 mg/kg ip; n = 12), or 8-Cyclopentyl-1, 3-dipropylxanthine (DPCPX) (1.0 mg/kg ip; n = 8) was applied before preconditioning during 1.0% halothane anesthesia. Temporary occlusion (120 min) of the right middle cerebral artery was induced 4 days after preconditioning and the infarct volume was measured. Preconditioning elicited under 1.0% halothane reduced cortical infarct volume from 277 +/- 15 mm3 in the control group to 159 +/- 14 mm3 in the CSD group (mean +/- SEM, P < 0.05). In contrast, CSD induced during inhalation of 0.5% or 2.0% halothane did not confer ischemic tolerance. The reduction in infarct area with CSD during inhalation of 1% halothane was not changed in animals treated with glibenclamide or 5-HD or DPCPX. These results uncover a crucial role of halothane level but not of K(ATP) channels or adenosine A1 receptors in the preconditioning effects of CSD.
机译:我们调查了ATP敏感钾(K(ATP))通道,腺苷A1受体以及不同水平的氟烷麻醉在CSD诱导的缺血性耐受性发展中的影响。为了引发CSD,将0.5米KCl施加2小时,向卤化卤素麻醉的雄性Wistar大鼠右半球。 CSD期间氟烷的吸入浓度保持在0.5%(n = 8),1.0%(n = 8),或2.0%(n = 8)。对于对照动物,施用盐水代替KCl(n = 8)。抑制K(ATP)通道或腺苷A1受体,Glibenclamide(0.1mg / kg ICV; n = 8),5-羟基二芳酸盐(5-Hd; 100mg / kg IP; n = 12),或8-环戊基-1在1.0%氟烷麻醉期间预处理之前施加3-二丙基黄嘌呤(DPCPX)(1.0mg / kg IP; n = 8)。在预处理后4天诱导右中脑动脉的临时闭塞(120分钟),并测量梗塞体积。在1.0%氟烷下引起的预处理在对照组中的277 +/-15mm 3减少了皮质梗塞体积,在CSD组中的159 +/-14mm 3(平均+/- SEM,P <0.05)。相反,在吸入0.5%或2.0%氟烷期间诱导的CSD不赋予缺血性耐受性。在用Glibenclamide或5-HD或DPCPX处理的动物中,在吸入1%氟烷期间,在吸入1%氟烷期间的梗塞区域的减少。这些结果揭示了氟烷水平但不含K(ATP)通道或腺苷A1受体在CSD的预处理作用中的关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号